Home / Specialties... / Doctors
Danqing Yu/Director

Specialties: Cardiology


Clinical interests: Percutaneous coronary intervention; Medical treatment for patients with coronary heart disease, hypertension, valvular heart disease, heart failure and cardiomyopathy.


Bio:
1989.07-1994.09 Resident in department of cardiology, Guangdong Provincial People’s Hospital
1995.09-2001.09 Attending physician in department of cardiology, Guangdong Provincial People’s Hospital
2001.09-2007.11 Vice chief physician in department of cardiology, Guangdong Provincial People’s Hospital
2003.06-2003.09 Visiting scholar in University of Duisburg-Essen, German
2007.11-now Chief physician in department of cardiology, Guangdong Provincial People’s Hospital


Education:
1984.09-1989.07 Sun Yat-sen University of Medical Sciences, Guangzhou, Guangdong, China, BD


Awards and Honors:
She won the second prize of Guangdong Scientific and Technical Awards for her study of “Clinical Application of Comprehensive Interventional Therapy in Ischemic Heart Disease with atherosclerosis” and won the title of “Good doctor in the City of Rams” in 2019.


Professional memberships:
1. Review expert of Natural Science Foundation of Guangdong Province, China
2. Fellow of European Society of Cardiology (FESC) and American College of Cardiology (FACC)
3. Member of Women’s Heart Health Group, Chinese Society of Cardiology
4. Member of Guangdong College of Cardiovascular Interventional Physicians
5. Vice chairman of The China Great Bay Area Heart Association
6. Vice Director of Coronary Imaging and Function Committee, Guangdong Society of Interventional Cardiology
7. Director of Women Cardiovascular Disease Committee, Guangdong Society of Interventional Cardiology
8. Director of Guangdong Society of Interventional Cardiology


Publications:

1. Liu Y, Ma H, Zhu Q, Zhang B, Yan H, Li H, Meng J, Lai W, Li L, Yu D, Zhong S. A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population. J Lipid Res. 2019 Aug;60(8):1440-1448.
2. Wei XB, Jiang L, Liu YH, Feng D, He PC, Chen JY, Tan N, Yu DQ. Thrombocytopenia as a Preoperative Risk Assessment Tool in Patients With Rheumatic Heart Disease Undergoing Valve Replacement Surgery. J Am Heart Assoc. 2017 Dec 4;6(12):e006988.
3. Wei XB, Jiang L, Liu YH, Feng D, He PC, Chen J, Yu DQ, Tan N. Serum uric acid as a simple risk factor in patients with rheumatic heart disease undergoing valve replacement surgery. Clin Chim Acta. 2017 Sep;472:69-74.
4. Wei XB, Jiang L, Liu YH, Feng D, He PC, Chen JY, Yu DQ, Tan N. Prognostic value of hypoalbuminemia for adverse outcomes in patients with rheumatic heart disease undergoing valve replacement surgery. Sci Rep. 2017 May 16;7(1):1958.
5. Wei XB, Liu YH, He PC, Yu DQ, Tan N, Zhou YL, Chen JY. The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis. Clin Chem Lab Med. 2017 May 1;55(6):899-906.